PlexBio Co., Ltd. (TPEX:6572)

PlexBio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	128.06	167.18	191.19	124.94	101.35
Revenue Growth (YoY)	-23.40%	-12.56%	53.02%	23.28%	42.38%
Cost of Revenue	78.8	104.71	132.19	86.38	59.67
Gross Profit	49.26	62.47	59	38.56	41.68
Selling, General & Admin	59.5	63.65	53.32	60.51	76.62
Research & Development	69.29	62.97	72.61	113.31	113.37
Operating Expenses	128.79	126.62	125.93	173.82	189.99
Operating Income	-79.53	-64.15	-66.94	-135.26	-148.31
Interest Expense	-0.16	-0.26	-0.17	-0.23	-0.23
Interest & Investment Income	9.58	8.27	3.01	2.31	4.21
Currency Exchange Gain (Loss)	7.84	-2.88	10.06	-2.01	-4.94
Other Non Operating Income (Expenses)	0.63	0.49	0.9	4.08	13.53
EBT Excluding Unusual Items	-61.63	-58.53	-53.14	-131.11	-135.74
Gain (Loss) on Sale of Assets	-	-	-	-0.48	-5.33
Pretax Income	-61.63	-58.53	-53.14	-131.59	-141.07
Net Income	-61.63	-58.53	-53.14	-131.59	-141.07
Net Income to Common	-61.63	-58.53	-53.14	-131.59	-141.07
Shares Outstanding (Basic)	104	104	104	104	103
Shares Outstanding (Diluted)	104	104	104	104	103
Shares Change (YoY)	-	-	0.11%	0.51%	28.99%
EPS (Basic)	-0.59	-0.56	-0.51	-1.27	-1.37
EPS (Diluted)	-0.59	-0.56	-0.51	-1.27	-1.37
Free Cash Flow	-8.64	-32.11	-73.02	-95.94	-116.71
Free Cash Flow Per Share	-0.08	-0.31	-0.70	-0.93	-1.13
Gross Margin	38.46%	37.37%	30.86%	30.86%	41.13%
Operating Margin	-62.10%	-38.38%	-35.01%	-108.26%	-146.34%
Profit Margin	-48.13%	-35.01%	-27.79%	-105.32%	-139.19%
Free Cash Flow Margin	-6.75%	-19.21%	-38.19%	-76.78%	-115.16%
EBITDA	-69.67	-55.06	-55.76	-121.46	-132.73
EBITDA Margin	-54.40%	-32.93%	-29.17%	-97.21%	-130.97%
D&A For EBITDA	9.86	9.09	11.17	13.8	15.58
EBIT	-79.53	-64.15	-66.94	-135.26	-148.31
EBIT Margin	-62.10%	-38.37%	-35.01%	-108.26%	-146.34%

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.